Citi Pharma Limited announced earnings results for the year ended June 30, 2021. For the full year, the company reported turnover- net was PKR 5,795,403,997 against PKR 3,527,625,000 a year ago. Operating profit was PKR 570,970,332 against PKR 254,114,103 a year ago. Profit after taxation was PKR 351,768,295 against PKR 143,416,468 a year ago. Basic earnings per share was PKR 4.64 against PKR 31.87 a year ago. Diluted earnings per share was PKR 2.36 against PKR 31.87 a year ago.